Cannabis Learning EDU

Clinical Endocannabinoid Deficiency (CED) Research
hyperlink to scholar search of CED - 18K+ results
Russo, E.B.
Cannabis and Cannabinoid Research. 2016, 1(1): 154-165 (full).
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity
Schlabritz-Loutsevitch, Natalia, et al.
Medical Hypotheses. 2016 Nov, 96: 35-38 (abstract).
Beyond Cannabis: Plants and the Endocannabinoid System
Russo, E.B.
Trends in Pharmacological Sciences. 2016 Jul, 37(7): 594-605 (abstract).
Expression of the Endocannabinoid Receptors in Human Fascial Tissue
Fede, C, et al.
European Journal of Histochemistry. 2016, 60:2643: 130-134 (full).
Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
Jenniches, Imke, et al.
Biological Psychiatry: A Journal of Psychiatric Neuroscience and Therapeutics. 2016 May, 79(10): 858-868 (abstract).
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Pryce, Gareth, et al.
Endocannabinoids, Handbook of Experimental Pharmacology. 2015, 231: 213-231 (abstract).
Kishimoto, Yusushi, et al.
Frontiers in Behavioral Sciences. 2015 Jun 2, 9(134): 1-14 (full).
Sulak, Dustin D.O.
O’Shaughnessy’s. 2015/16 Winter Issue: 3-7 (full).
McPartland, John M., et al.
British Journal of Pharmacology. 2015, 172: 737-753 (full).
Shonesy, Brian C, et al.
Cell Reports. 2014 Dec 11, 9: 1644-1653 (full).
Bluett, RJ, et al.
Translational Psychiatry. 2014 Jul 8, 4(e408) (full).
McPartland, John M., et al.
PlosOne. 2014 Mar 12, online article (full).
Modulating the endocannabinoid system in human health and disease - successes and failures
Pacher, Pal, et al.
The FEBS Journal. 2013 Mar, 280: 1918-1943 (full).
Effect of Cannabinoid Receptor Activation on Spreading Depression
Kazemi, Hadi, et al.
Iranian Journal of Basic Medical Sciences. 2012 Jul, 15(4): 926-936 (full).
CB1 receptor-deficient mice as a model for depression
Valverde, O., et al.
Neuroscience. 2012 Mar 1, 204: 193-206 (abstract).
Effects of anandamide in migraine: data from an animal model
Greco, Rosaria, et al.
The Journal of Headache and Pain. 2011 Apr, 12(2): 177-183 (abstract).
Endocannabinoid system dysfunction in mood and related disorders
Ashton, C.H., et al.
Acta Psychiatrica Scandinavica. 2011 Oct, 124(4): 250-261 (abstract).
Wang, Wei, et al.
Neuropsychopharmacology. 2010, 35: 2249-2261 (full).
Review on clinical studies with cannabis and cannabinoids 2005-2009
Hazekamp, Arno, et al.
Cannabinoids. 2010, 5(special issue): 1-21 (full).
The endocannabinoid system and migraine
Greco, Rosaria, et al.
Experimental Neurology. 2010 Jul, 224(1): 95-91 (abstract).
Russo, E.B.
Neuro Endocrinology Letters. 2008 Apr 1, 29(2): 192-200 (abstract).
Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System Failure
Sarchielli, Paola, et al.
Neuropsychopharmacology. 2007, 32: 1384-1390 (full).
A possible role for the endocannabinoid system in the neurobiology of depression
Serra, Gino, et al.
Clinical Practice and Epidemiology in Mental Health. 2007 Nov 19, 3:25: 1-11 (full).
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
Massa, Federico, et al.
Journal of Molecular Medicine. 2005 Dec, 83(12): 944-954 (abstract).
Agonistic Properties of Cannabidiol at 5-HT1a Receptors
Russo, E.B., et al.
Neurochemical Research. 2005 Aug, 30(8): 1037-1043 (abstract).
Therapeutic opportunities through modulation of the endocannabinoid system
Makriyannis, Alexandros, et al.
Neuropharmacology. 2005, 48: 1068-1071 (full).
Lutz, Beat.
Biochemical Pharmacology. 2004 Nov 1, 68(9): 1691-1698 (abstract).